KPTI
Karyopharm Therapeutics Inc
0.605$
+0.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.3% | -1.8% | +29.2% | -9.4% | -21.2% | -1.7% | +26.4% | +16.1% | -22.6% | +2.9% | -4.7% | – | |
| – | +71.6% | +27.7% | -22.0% | -16.5% | +2.4% | -2.3% | -19.2% | +101.0% | -29.8% | -8.6% | -20.0% | – | |
| – | -8.3% | -3.3% | +32.4% | -9.1% | -22.1% | -1.7% | +28.4% | +13.7% | -22.3% | +3.4% | -4.0% | – | |
| – | +10.6% | -10.1% | +8.3% | -5.6% | -7.8% | +4.0% | -5.3% | -6.8% | -9.4% | +22.1% | -11.4% | – | |
| – | -0.4% | -3.7% | +5.1% | -11.1% | -1.6% | +0.6% | +4.1% | -6.6% | -14.4% | +17.2% | -2.9% | – | |
| – | +5.5% | -7.3% | +6.9% | -8.1% | -5.1% | +2.4% | -1.1% | -6.7% | -11.7% | +19.9% | -9.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.2% | -5.2% | +52.1% | +27.2% | -1.6% | -1.9% | +2.1% | -2.0% | +14.6% | -0.5% | +4.7% | – | |
| – | – | – | – | -234.3% | – | – | – | – | – | – | – | – | |
| – | +983.3% | -45.4% | -5.6% | -58.2% | -489.3% | – | +11.1% | -15.0% | -297.1% | – | – | – | |
| – | – | – | – | -234.8% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -162.5% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.